- Home
- VTYX vs ORGN Comparison
VTYX vs ORGN Comparison
Compare VTYX & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- ORGN
- Stock Information
- Founded
- VTYX 2018
- ORGN 2008
- Country
- VTYX United States
- ORGN United States
- Employees
- VTYX N/A
- ORGN N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- ORGN Major Chemicals
- Sector
- VTYX Health Care
- ORGN Industrials
- Exchange
- VTYX Nasdaq
- ORGN Nasdaq
- Market Cap
- VTYX 154.9M
- ORGN 131.4M
- IPO Year
- VTYX 2021
- ORGN N/A
- Fundamental
- Price
- VTYX $3.65
- ORGN $0.66
- Analyst Decision
- VTYX Buy
- ORGN
- Analyst Count
- VTYX 3
- ORGN 0
- Target Price
- VTYX $10.00
- ORGN N/A
- AVG Volume (30 Days)
- VTYX 1.5M
- ORGN 1.0M
- Earning Date
- VTYX 11-06-2025
- ORGN 11-13-2025
- Dividend Yield
- VTYX N/A
- ORGN N/A
- EPS Growth
- VTYX N/A
- ORGN N/A
- EPS
- VTYX N/A
- ORGN N/A
- Revenue
- VTYX N/A
- ORGN $28,667,000.00
- Revenue This Year
- VTYX N/A
- ORGN $49.18
- Revenue Next Year
- VTYX N/A
- ORGN $144.81
- P/E Ratio
- VTYX N/A
- ORGN N/A
- Revenue Growth
- VTYX N/A
- ORGN N/A
- 52 Week Low
- VTYX $0.78
- ORGN $0.40
- 52 Week High
- VTYX $4.05
- ORGN $1.53
- Technical
- Relative Strength Index (RSI)
- VTYX 62.22
- ORGN 65.78
- Support Level
- VTYX $3.48
- ORGN $0.51
- Resistance Level
- VTYX $4.04
- ORGN $0.59
- Average True Range (ATR)
- VTYX 0.30
- ORGN 0.04
- MACD
- VTYX 0.04
- ORGN 0.02
- Stochastic Oscillator
- VTYX 72.93
- ORGN 93.61
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.